For young people with Autistic Spectrum Disorder (ASD), everyday settings such as a busy classroom, shopping centre or public transport, can cause anxiety and phobias.
For young people with Autistic Spectrum Disorder (ASD), everyday settings such as a busy classroom, shopping centre or public transport, can cause anxiety and phobias.
The Blue Room is a virtual reality treatment that provides a controlled space for young people to face these scenarios. During the treatment, trained specialists help patients through situations within a personalized virtual reality space.
Many autistic people have difficulty creating scenarios using their imagination, which can make treatment of phobias difficult. Additionally, phobias and anxieties differ greatly from one person to the next. This is where the Blue Room comes in.
We have created over 50 scenarios which we can alter for each patient’s needs. These are used to help patients overcome their anxieties of social interactions, objects or animals. Examples of available scenarios include dogs, wasps/bees, lifts, fear of the dark, flying, school, walking into rooms, getting onto crowded public transport, crossing a bridge or talking to a shop assistant.
The Blue Room is a purpose-built virtual reality space built for people with ASD. Besides the wide range of scenarios it can simulate, it tackles many of the challenges of treating people with ASD. Each scenario can gradually increase both the complexity and noise level, allowing for controlled exposure – which cannot be achieved in real life.
Virtual reality headsets and goggles can distress people with ASD. Instead, Blue Room provides a room-sized space by projecting onto the walls, ceiling and floor. Patients have full control of their movement using a touch tablet, letting them progress at a pace they are comfortable with.
Overwhelming sensory input is a common problem for people with ASD in many everyday situations. The Blue Room provides safe exposure to these situations, as each scenario can be changed to reduce or increase the visual complexity and noise levels of the space.
Controlled trials have shown that 40% of the children treated at the Blue Room showed growth in coping with a real life situation after just 2 weeks. This grew to 45% after 6 months. These results are similar to other methods and the team is focused on how to further increase the rate of positive responses.
In a separate trial, the Blue Room treated eight autistic adults. Each participant completed four 20-minute sessions. After six months, five of the adults reported ongoing improvements related to their phobia.
Blue Room has been developed by a team at Newcastle University, utilising technology developed by Third Eye Technologies. In the UK alone, around 150,000 children are thought to have ASD. The NHS is offering the Blue Room as a treatment method for children with autism aged from 7-17.
Purchase the ILO today to directly support the widespread use of our technology, and ensure a better future for those with ASD.
We promise to pay a royalty of 10% of all sales (revenue) made by Blue Room, divided evenly among qualified license holders.
Our projected revenues are as follows:
In addition to paying you a royalty, at the end of the 3rd year we can choose to extend the license for another 3 years, or buy the ILO back for cash should we conduct a major financing.
ILO Value is the estimated value of your ILO in USD ($). This is calculated using our projected revenue numbers. Therefore if our revenue projections are realistic and achievable, this is a good estimation of the buy out price you should expect at different stages.
THIS AGREEMENT is between Neurotech Solutions (UK) Ltd (“the Company”), - AND – The Buyer who is the Current License Holder as determined by the Live Ledger held by ILOCX which holds details of licenses issued bought and sold (“the Buyer”).
July 12, 2019
Details of the Licensed Product are described on the Company’s page hosted on the site at www.ILOCX.com
None
Minimum Requirements for Qualification are a confirmed share of the Company’s information and Promotional Message on social media. This can be done on the ILOCX platform. Alternative ways to qualify are at the discretion of the company selling the license.
$40
Under the License Agreement the buyer is entitled to royalty payments once qualified
Each License receives a royalty equal to 10% of the Gross Revenues from the recorded and officially filed revenue, divided by 40000, the total amount of ILO Units in the Initial Licence Offering. All royalties will be paid to the Buyer’s wallet on the ILOCX platform within 5 days of payment settlement from the company. These days will be announced prior to release.
This License is for an Initial Term of 3 years at which time the Licence can be extended by the issuing Company for a further 3 years, (a “Rollover”) and new terms may be set by the company at this time in line with ILOCX exchange rules and guidelines. Alternatively, the Company may offer to buy the License back from the Buyer (“a ‘Buyback”). The Company will give notice of Rollover terms or Buyback Price 90 days before the end of the Initial Term, as outlined in the Buyer Terms and Conditions.
All licenses must be valid and deemed qualified to benefit from the Royalty and the Rollover or Buyback.
This Agreement should be read in conjunction with the License Terms and Conditions, the Company Terms and Conditions, the Buyer Terms and Conditions and the ILOCX Terms of Use which form part of this entire Agreement, as well all ILOCX rules, policies, rulings and procedural requirements (collectively the “ILOCX Terms and Conditions”).
All parties have read and agreed to comply with the ILOCX Terms and Conditions, this Agreement, and any documents included by reference above. These may be amended from time to time and the parties will be notified by email of such amendments. Breach of any of the terms of this agreement may result in termination of this Agreement under the termination procedures outlined in the License Terms and Conditions.
This Agreement shall be governed by the laws of England and Wales and the parties exclusively submit to the jurisdiction of the Courts of England and Wales. In the event of any dispute, refer to the terms and conditions for the procedure.
Agreed on behalf of the Company:
The Company confirms its consent to this License Agreement by presenting the ILO for sale on the ILOCX platform.
Agreed on behalf of the Buyer:
The Buyer consents to this agreement by completing their order on ILOCX.
Leading experts from Newcastle University, working with Third Eye Technologies, are using cutting edge virtual reality to help children with autism overcome their fears.
Fears and phobias are common among people with ASD, and can hinder their everyday activities, learning and social life. A pilot study shows the Blue Room can help treat these fears in adults too.
Third Eye NeuroTech’s Blue Room immersive virtual reality (VR) technology is in the spotlight following the publication of research which revealed its effectiveness in treating phobias and anxieties for children and adults...
The Blue Room, developed by specialists at Newcastle University working alongside innovative technology firm Third Eye NeuroTech, allows the team to create a personalised 360 degree environment involving the fear which may debilitate the person with autism in real life...
4D Vision was founded to develop revolutionary green power solutions, tackling the biggest challenges in renewable energy.
The National Academy of Athletics is on a mission to bring sports to children throughout the USA.
CleanerBlast has a 10 dollar proposition to take over the billion dollar industry you’ve never heard of… RUST.
Conflow Power has developed the smartest of smart street lighting, that uses the grid as a backup and incorporates a range of technologies from cameras, and 5G transmitters, to gunshot detection and weather and air quality monitoring stations.
